Glen Eagle Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-455
Closed -$25.8K 1021
2025
Q4
$25.8K Buy
+455
New +$24.8K ﹤0.01% 542
2024
Q2
Sell
-105
Closed -$3.2K 1150
2024
Q1
$3.2K Buy
+105
New +$3.16K ﹤0.01% 845
2023
Q1
Sell
-35
Closed -$1.4K 1097
2022
Q4
$1.4K Buy
+35
New +$1.38K ﹤0.01% 958
2021
Q2
Sell
-45
Closed -$1.74K 1046
2021
Q1
$1.74K Hold
45
﹤0.01% 890
2020
Q4
$1.69K Buy
+45
New +$1.61K ﹤0.01% 865

Other funds holding BTI

Glen Eagle Advisors's BTI Position: Q1 2026 in Review

Glen Eagle Advisors sold out of British American Tobacco (BTI) in Q1 2026, closing a stake of 455 shares — an estimated $25.8K sold.

Glen Eagle Advisors first reported a position in BTI in Q4 2020 and held it in 5 quarters. The position peaked at $25.8K in Q4 2025. 869 funds tracked by Wall St. Rank hold BTI as of Q1 2026.

  • Glen Eagle Advisors reported no remaining British American Tobacco position as of Q1 2026 after selling out during the quarter.
  • Glen Eagle Advisors sold 455 British American Tobacco shares in Q1 2026, an estimated $25.8K.
  • Glen Eagle Advisors first reported a position in British American Tobacco in Q4 2020 and held it in 5 quarters.
  • Glen Eagle Advisors's British American Tobacco position peaked at $25.8K in Q4 2025.
  • 869 funds tracked by Wall St. Rank held British American Tobacco as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.